Histopathological evaluation further revealed that mice receiving supplemental IL-1β exhibited sustained hyperkeratosis, acanthosis, and prominent perivascular inflammatory cell infiltration in the dermis compared to the brusatol-only group (Fig. 8A). The gene discussed is IL1B; the disease is Hyperkeratosis.